aneurysmal :
Search Words
News & Articles
- Vasospasm 2013 Conference Features Oral Presentation of Edge Therapeutics’ EG-1962
Edge Therapeutics today announced that researchers from Heinrich Heine University in Düsseldorf, Germany presented positive results of the first clinical application of EG-1962 , a sustained release injectable formulation of nimodipine for improvement of outcome and prevention of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage .
July 12, 2013 - Business Wire via Yahoo! Finance